Valenza Marta, Butelman Eduardo R, Kreek Mary Jeanne
The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, 1230 York Avenue - Box 171, New York, NY, 10065, USA.
Psychopharmacology (Berl). 2017 Aug;234(15):2219-2231. doi: 10.1007/s00213-017-4647-0. Epub 2017 May 27.
The recruitment of the stress circuitry contributes to a shift from positive to negative reinforcement mechanisms sustaining long-term cocaine addiction. The kappa opioid receptor (KOPr) signaling is upregulated by stress and chronic cocaine exposure. While KOPr agonists induce anhedonia and dysphoria, KOPr antagonists display antidepressant and anxiolytic properties. Most of the knowledge on KOPr antagonism is based on drugs with unusual pharmacokinetic and pharmacodynamic properties, complicating interpretation of results. Here we characterized in vivo behavioral and neuroendocrine effects of the novel relatively short-acting KOPr antagonist LY2444296. To date, no study has investigated whether systemic KOPr blockade reduced anxiety-like and depressive-like behaviors in animals previously exposed to chronic extended access cocaine self-administration.
We tested the effect of LY2444296 in blocking KOPr-mediated aversive and neuroendocrine effects. Then, we tested acute systemic LY2444296 in reducing anxiety- and depression-like behaviors, as well as releasing the stress hormone corticosterone (CORT), observed after chronic extended access (18 h/day for 14 days) cocaine self-administration.
LY2444296 blocked U69,593-induced place aversion and -reduced motor activity as well as U69,593-induced release of serum CORT, confirming its major site of action, without exerting an effect per se. Acute systemic administration of LY2444296 reduced anxiety-like and depressive-like behaviors, as well as CORT release, in rats tested after chronic extended access cocaine self-administration, but not in cocaine-naïve rats.
Results suggest that acute blockade of KOPr by a relatively short-acting antagonist produces therapeutic-like effects selectively in rats with a history of chronic extended access cocaine self-administration.
应激回路的激活促使维持长期可卡因成瘾的强化机制从正向转变为负向。κ阿片受体(KOPr)信号通路在应激和长期可卡因暴露时会上调。虽然KOPr激动剂会诱发快感缺失和烦躁不安,但KOPr拮抗剂具有抗抑郁和抗焦虑特性。关于KOPr拮抗作用的大多数知识都基于具有异常药代动力学和药效学特性的药物,这使得结果的解释变得复杂。在此,我们对新型作用相对短效的KOPr拮抗剂LY2444296的体内行为和神经内分泌效应进行了表征。迄今为止,尚无研究调查全身性KOPr阻断是否能减少先前长期接触可卡因自我给药的动物的焦虑样和抑郁样行为。
我们测试了LY2444296阻断KOPr介导的厌恶和神经内分泌效应的作用。然后,我们测试了急性全身性给予LY2444296对减少焦虑样和抑郁样行为以及释放应激激素皮质酮(CORT)的影响,这些行为和激素变化是在长期延长给药时间(每天18小时,持续14天)的可卡因自我给药后观察到的。
LY2444296阻断了U69593诱导的位置厌恶并降低了运动活性,同时减少了U69593诱导的血清CORT释放,证实了其主要作用位点,且本身无效应。急性全身性给予LY2444296可减少长期延长给药时间的可卡因自我给药后测试的大鼠的焦虑样和抑郁样行为以及CORT释放,但对未接触过可卡因的大鼠无效。
结果表明,相对短效的拮抗剂急性阻断KOPr能在有长期延长给药时间的可卡因自我给药史的大鼠中选择性地产生类似治疗的效果。